Evaluation and comparison of thirty noninvasive models for diagnosing liver fibrosis in chinese hepatitis B patients
In conclusion, in Chinese CHB patients, the 30 existing noninvasive models were not suitable for assessing each stage of fibrosis except cirrhosis before and after antiviral therapy, especially in gauging progression and regression of liver fibrosis following therapy.
Source: Journal of Viral Hepatitis - Category: Infectious Diseases Authors: Xiao ‐Qin Dong,
Zhao Wu,
Hong Zhao,
Gui‐Qiang Wang,
China HepB‐Related Fibrosis Assessment Research Group Tags: ORIGINAL ARTICLE Source Type: research
More News: Antiviral Therapy | China Health | Cirrhosis | Hepatitis | Hepatitis B | Infectious Diseases | Liver | Urology & Nephrology